| 1 |
At-risk population |
Total population in the endemic implementation unit(s). It includes both eligible and ineligible population [20]. |
| 2 |
Target population for MDA |
The population in an implementation unit that is targeted for treatment. This includes those who are eligible to receive the drugs based on safety criteria [11, 20]. |
| 3 |
Directly observed treatment (DOT) or (DOT-MDA) |
The only method to ensure an individual swallowed a drug or a combination of drugs [20]. |
| 4 |
Coverage rate |
Proportion of eligible population who received DEC & Albendazole [13]. |
| 5 |
Compliance rate |
Proportion of people who consumed the drug out of those who received it [14]. |
| 6 |
Coverage Compliance gap |
Proportion of those who received DEC but did not consume it [14]. |
| 7 |
Reported coverage |
Intervention coverage calculated from data reported by all drug administrators [13, 20]. |
| 8 |
Drug (Effective) Coverage rate |
The proportion of individuals, expressed as a percentage, in a targeted population who swallowed a drug, or a combination of drugs; the denominator is eligible/targeted population [11, 13,14, 20]. |
| 9 |
Epidemiological drug Coverage |
The proportion of individuals in the implementation unit who have ingested the MDA drugs of the total population in the implementation unit; the denominator is total population [11, 13, 20]. |
| 10 |
Microfilaria rate (Mf%) |
Number of slides positive for microfilaria from total number of slides examined [11, 12, 21]. |
